透析中骑行对左心室质量影响的随机对照试验
CYCLE-HD试验为前瞻性开放标签单盲整群随机对照试验,评估六個月透析中骑行对左心室质量的影响。结果显示骑行组左心室质量显著降低(组间差-11.1g,95%CI -15.79至-6.43),且native T1 mapping和主动脉脉搏波速度亦显著改善,运动未增加室性心律失常,安全可行。
要点
- 六個月透析中骑行可显著降低左心室质量,组间差-11.1g(95%CI -15.79至-6.43)。
- 骑行组native T1 mapping和主动脉脉搏波速度显著改善,提示心肌纤维化和主动脉僵硬度获益。
- 运动未增加室性期前收缩或复杂室性心律失常,安全耐受性好。
核心结论
- 六個月透析中骑行计划可降低左心室质量,且安全、可实施、耐受良好。
研究设计与样本
- 前瞻性、开放标签、单盲、整群随机对照试验(CYCLE-HD),预设检验左心室质量15g差异。
- 招募130例完成基线评估(每组65例),最终101例完成试验方案(对照组50例,运动组51例)。
主要发现
- 六個月透析中骑行组较对照组左心室质量显著降低,组间差-11.1g(95%CI -15.79至-6.43)。
- 敏感性分析(缺失数据填补)后左心室质量降低仍显著,差-9.92g(95%CI -14.68至-5.16)。
- native T1 mapping和主动脉脉搏波速度组间比较均显著改善, favoring干预组。
- 运动未增加室性期前收缩或复杂室性心律失常,对躯体功能或生活质量无显著影响。
关键数值与推荐
- 主要终点为心脏MRI测量的左心室质量,预设检测组间15g差异。
- 预设次要结局包括心肌纤维化、主动脉僵硬度、躯体功能、生活质量和室性心律失常。
临床怎么用
- 透析中骑行可作为安全、可实施的干预,有助于改善透析患者左心室质量和心血管预后指标。
局限性
- 开放标签设计,仅评估者设盲;最终完成方案者101例,存在缺失数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular disease is the leading cause of death for patients receiving hemodialysis. Since exercise mitigates many risk factors which drive cardiovascular disease for these patients, we assessed effects of a program of intra-dialytic cycling on left ventricular mass and other prognostically relevant measures of cardiovascular disease as evaluated by cardiac MRI (the CYCLE-HD trial). This was a prospective, open-label, single-blinded cluster-randomized controlled trial powered to detect a 15g difference in left ventricular mass measured between patients undergoing a six-month program of intra-dialytic cycling (exercise group) and patients continuing usual care (control group). Pre-specified secondary outcomes included measures of myocardial fibrosis, aortic stiffness, physical functioning, quality of life and ventricular arrhythmias. Outcomes were analyzed as intention-to-treat according to a pre-specified statistical analysis plan. Initially, 130 individuals were recruited and completed baseline assessments (65 each group). Ultimately, 101 patients completed the trial protocol (50 control group and 51 exercise group). The six-month program of intra-dialytic cycling resulted in a significant reduction in left ventricular mass between groups (-11.1g; 95% confidence interval -15.79, -6.43), which remained significant on sensitivity analysis (missing data imputed) (-9.92g; 14.68, -5.16). There were significant reductions in both native T1 mapping and aortic pulse wave velocity between groups favoring the intervention. There was no increase in either ventricular ectopic beats or complex ventricular arrhythmias as a result of exercise with no significant effect on physical function or quality of life. Thus, a six-month program of intradialytic cycling reduces left ventricular mass and is safe, deliverable and well tolerated.
引用
- Graham-Brown MPM, March DS, Young R, et al. A randomized controlled trial to investigate the effects of intra-dialytic cycling on left ventricular mass. Kidney Int. 2021. PMID: 34023029. doi:10.1016/j.kint.2021.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。